Molecular point-of-care detection of infectious disease - as sensitive as central lab tests and as fast & inexpensive as rapid antigen tests
Lucigen is a successful life sciences/research tools company in the molecular biology arena. We are highly-regarded for our cloning, phage display, protein engineering and enzyme discovery. Amongst our customers are leading companies such as Novartis, Pfizer and Life Technologies. Lucigen has been profitable and cash-flow positive since 2007. We are seeking to enter the clinical diagnostics space, leveraging our patented PyroScript(R) enzyme.